This inventor holds 2 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Shun Su: Innovator in RXFP1 Agonists
Introduction
Shun Su is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmacology, particularly through his work on RXFP1 agonists. With a focus on innovative solutions, Shun has secured a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Shun Su holds a patent for RXFP1 agonists, which highlights his commitment to developing new therapeutic options. This patent represents a crucial step in understanding and potentially treating various health conditions.
Career Highlights
Shun is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role at Bristol-Myers Squibb allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Shun Su works alongside his coworker, Arvind Mathur, fostering a collaborative environment that encourages innovation and the sharing of ideas. Their partnership exemplifies the importance of teamwork in achieving scientific advancements.
Conclusion
Shun Su is a dedicated inventor whose work on RXFP1 agonists has the potential to impact the medical field significantly. His contributions at Bristol-Myers Squibb Company reflect his commitment to innovation and improving patient outcomes.